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Type 1 diabetes mellitus
TreatmentAims: Self-management (self-monitoring of blood glucose, plus self-adjustment of insulin
dose) is important in diabetes care, but its complexity presents a barrier to wider imple-
mentation, which hinders attainment and maintenance of glycemic targets. More evidence
on self-management is needed to increase its implementation and improve metabolic out-
comes.
Methods: Data from 1316 participants with type 1 diabetes mellitus who were enrolled from
Middle East countries into the International Diabetes Management Practices Study (IDMPS),
a multinational observational survey, were analyzed to assess the impact of education on
disease management and outcomes.
Results: A majority (78%) of participants failed to achieve glycemic target (HbA1c < 7.0%
[<53 mmol/mol]). Participants who had received diabetes education (59%) were more likely
to practice self-management than those who had not (odds ratio [OR]: 2.51; 95% confidence
interval [CI]: 1.7–3.69; p < 0.001), and those who practiced self-management were more
likely to attain target HbA1c than those who did not (OR: 1.49; 95% CI: 1.06–2.09; p = 0.023).l Research
e.Domen-
30 d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 4 7 ( 2 0 1 9 ) 2 9 –3 6Conclusions: These relationships between diabetes education, self-management and glyce-
mic control suggest that diabetes education provides knowledge and skills to optimize self-
management, favoring HbA1c target attainment. Middle East health authorities should
search for ways to facilitate access to diabetes education to optimize treatment outcomes.
 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Poor glycemic control of type 1 diabetes mellitus (T1DM) is
associated with serious long-term complications that impact
negatively on quality of life and increase both direct and
indirect costs of the disease [1,2]. Intensive insulin therapy
combined with dose adjustments based on self-monitoring
blood glucose (SMBG) measurements, facilitates attainment
of glycated hemoglobin (HbA1c) target values, decreasing the
risk of development and progression of chronic complications
[2,3]. However, this degree of control is difficult to
attain/ maintain in real-life situations due to barriers such as
the complexity and demands of diabetes self-management
and the occurrence and fear of hypoglycemia [2,4].
Structured education programs about diabetes self-
management can help to overcome these barriers, leading
to substantial improvements in glycemic control and other
diabetes outcomes. In Germany, following a 5-day inpatient
diabetes treatment and teaching program (DTTP), HbA1c fell
significantly from 8.1% (65 mmol/mol) to 7.3% (56 mmol/ mol)
over the subsequent year, with a significant reduction in
the number of severe hypoglycemic episodes [5]. Similarly,
in the UK, implementation of the Dose Adjustment For
Normal Eating (DAFNE) program, improved glycemic control
and quality of life while reducing 10-year costs by approxi-
mately £2200 per patient treated, without increasing the
risk of severe hypoglycemia [6,7]. Such treatment programs
have also improved outcomes (metabolic control and
treatment satisfaction) for patients with moderately
controlled T1DM receiving intensive insulin therapy [8].
Furthermore, these programs can also improve emotional
outcomes [9].
While results from these European programs show the
benefits of education about diabetes self-management,
there are limited data on this subject outside the Western
world. Since 2005, the International Diabetes Mellitus Prac-
tices Study (IDMPS) has been seeking to understand the
challenges of managing diabetes in the real world. Data
from IDMPS, the largest ever observational study program
that describes patient profiles, management and patterns
of care across time in developing regions, support the pro-
posed benefits of education [10]. Results from IDMPS
cohorts in Asia, Latin America and Eastern Europe have
been published previously [10–12]. This current manuscript
describes results for people with T1DM in the Middle East,
a region that has undergone major social and economic
changes over the last three decades. Its objective was to
investigate potential associations between diabetes educa-
tion, self-management and degree of glycemic control in
people with T1DM.2. Materials and methods
The design and objectives of the IDMPS study have been
described previously [10]. Briefly, IDMPS is an observational,
multinational study with the aim of assessing the therapeutic
management of people with type 2 diabetes mellitus (T2DM)
and T1DM in regular medical practice. Data collected
included: glycemic control; frequency of HbA1c testing; level
of screening for diabetes-related complications; and evalua-
tion of insulin dosing regimens used. The study was con-
ducted in six waves (Wave 1: 2005; Wave 2: 2006; Wave 3:
2008; Wave 4: 2010; Wave 5: 2011–12; Wave 6: 2013–14), each
of which included a cross-sectional survey; data from Waves
2–4 are reported here. Middle East Centers that participated in
Waves 2 onwards included Egypt, Iran (Wave 3 only), Lebanon,
Saudi Arabia, and the United Arab Emirates.
2.1. Study implementation
The study was coordinated by Sanofi-Diabetes Intercontinen-
tal. A steering committee integrated by an international group
of diabetologists advised the project team regarding study
design and registry structure, monitored study progress,
reviewed and validated all study-related documents, and pro-
posed decisions regarding protocol amendments, analyses
and publications. Ethics approval was obtained from institu-
tional review boards in each country and the study was con-
ducted in accordance with the Declaration of Helsinki.
2.2. Sample size estimation and selection of
centers/physicians
Sample sizes were determined for each country to estimate
the primary study endpoint (percentage of people with
T2DM treated with insulin), with 20% absolute precision and
95% confidence. The number of centers was determined
based on a recruitment target of ten people with T2DM per
center. In each country, a leading diabetologist compiled
and endorsed the list of investigators, who were then asked
to participate. They included endocrinologists, diabetologists,
and general practitioners with experience in initiation and
titration of insulin therapy [10]. Participating investigators/-
centers for each study wave were selected independently,
although investigators could participate in more than one
wave.
2.3. Participants
Physicians were asked to enroll the first ten peoplewith T2DM
and the first five people with T1DM (male or female) aged
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 4 7 ( 2 0 1 9 ) 2 9 –3 6 3118 years who attended their clinic over the 2-week recruit-
ment period. People could participate in only one wave. Any
patients who were actively participating in another clinical
study, or those receiving temporary insulin treatment (e.g.
for gestational diabetes or pancreatic cancer) were also
excluded. All participants provided written informed consent.
2.4. Data collection and outcome measures
Before each study wave, participating investigators recorded
their age, gender, specialty, care setting (hospital, private
office), experience in treating people with diabetes, and any
participation in diabetes educational programs.
Patient data, collected on case report forms, included:
demographics; socio-economic profile (urban vs rural home,
education level, health insurance coverage); diabetes medical
history, comorbidities and screening frequency for diabetes-
related complications; presence of diabetes complications;
physical measurements (including height, weight, blood pres-
sure and heart rate); cardiovascular risk factors (including
hypertension, lipid profile); glycemic control (including SMBG,
HbA1c monitoring frequency and last recorded value); history
of hypoglycemia; exercise frequency; current insulin treat-
ment (regimen, dose, insulin type, device); investigator opin-
ion on attainment of targets for glycemic control, blood
pressure and lipid status; patient’s diabetes education (e.g.
membership of support groups, type and modality of educa-
tion received); and level of follow-up care (number of visits
to physician/endocrinologist/diabetologist within previous
3 months).
Glycemic control was defined as HbA1c < 7.0%
(<53 mmol/ mol). Self-management was defined as SMBG
and self-adjustment of insulin dose.
2.5. Statistical analysis
Unless specified, data from all waves were pooled for analysis.
All case report forms were transferred from study centers to
Mapi, France, for quality control, transcription into electronic
format and analysis using SAS (version 9.2; SAS Institute, Cary,
NC). For variables with two modalities, Wilcoxon signed-rank
(quantitative variables) or Chi–squared (qualitative variables)
tests were used; for variables with more than two modalities,
Kruskal-Wallis (quantitative variables) or Fisher’s exact (qual-
itative variables) tests were used. Univariate and logistic
regression analyses were performed to identify predictive
factors for: self-management; patient’s diabetes education;
glycemic control. For the logistic regression, age was consid-
ered in three classes: <40 years old, 40–64 years old and
65 years old. Continuous variables included in the model
were: total daily insulin dose, time since diagnosis, time on
insulin treatment and waist circumference.
All predictors with a p-value <0.20 in univariate analysis
were included in a logistic regression model. Then, a stepwise
procedure was used to select the most relevant model. Start-
ing from a full model with all independent variables selected
based on the univariate analysis, all non-significant variables
were removed one by one until all parameters reached a level
of significance of at least 0.05. Interactions betweenindependent variables were not considered. Odds ratios were
provided with 95% confidence intervals (CIs). In all data analy-
ses, participants with missing data were not considered when
reporting proportions of participants in categories described.
3. Results
Clinical and metabolic characteristics of the 1316 participants
with T1DM (52% male) recruited by 762 investigators across
Waves 2–4 in the Middle East are listed in Table 1. The mean
(±SD) age of participants was 32.4 (±12.9) years, and most
(85%) were of Oriental/Arab/Persian ethnicity. Most partici-
pants (87%) lived in an urban setting, and 47% were educated
to university/higher level; 69% were covered by health insur-
ance and 79% had been seen by a GP at least once within
the previous 3 months. Basal plus prandial insulin was the
most commonly used regimen (51% overall), while 30% of par-
ticipants used premixed insulin alone.3.1. Diabetes education
Overall, 59% of participants had received diabetes education.
Most participants received diabetes education in an individual
rather than group setting.Mean age and disease durationwere
similar in diabetes-educated and non-educated groups. Basal
plus prandial insulin regimen was more common among
participants who had received diabetes education (60%) com-
pared with those who had not (39%, p < 0.001). The proportion
of participants who had received diabetes education was
similar whether recruited by a general practitioner (60% had
received education) or a diabetes specialist (58%).3.2. Self-management behaviors
Overall, 75% of participants practiced SMBG but only 54% of
participants practiced self-management (i.e. both SMBG and
insulin self-adjustment [ISA]). Overall, 16% of participants
practiced neither SMBG nor ISA (Table 1). Similarly,
self-management was more common among people with
university/higher education level than those with primary/
secondary education level (62 vs 45%, respectively; p < 0.001).
Self-management was significantly more common among
those who had received diabetes education compared with
those who had not (60 vs 41%, respectively; p < 0.001). Fig. 1
provides an overview of participant self-management
according to diabetes education status, excluding those who
reported practicing ISA alone (6% of overall population).3.3. Associations between glycemic control, diabetes
education and self-management
Overall, 22% of participants attained HbA1c target values
(HbA1c < 7.0% [<53 mmol/mol]). Target attainment was
significantly associated with diabetes education status: 25%
of participants who had received diabetes education attained
target values, compared with only 19% of those who had not
received education (p = 0.01, Fig. 2). Conversely, most
participants (52%) who did not receive diabetes education
Table 1 – Participant baseline characteristics, overall and according to diabetes education.
Overall (N = 1316)a Diabetes education status N = 1267b Significance (test used)
Educated n = 746 (59%) Not Educated n = 521 (41%)
Ethnicity, n (%) 0.365 (C)
Caucasian 76 (6) 51 (7) 24 (5)
South Asian 73 (6) 45 (6) 27 (5)
Black 13 (1) 7 (1) 2 (1)
Oriental, Arab, Persian 1123 (85) 630 (85) 455 (87)
Other Asian 29 (2) 12 (2) 12 (2)
Other 2 (<1) 1 (<1) 1 (<1)
Male, n (%) 678/1295 (52) 378/731 (52) 275/516 (53) 0.581
Mean age, years (SD) 32.4 (12.9) 31.0 (12.1) 34.3 (13.7) <0.001 (W)
Mean time since diabetes diagnosis, years (SD) 12.4 (9.3) 12.2 (8.9) 12.6 (9.8) 0.926
Mean BMI, kg/m2 (SD) 25.7 (4.9) 25.4 (4.8) 26.0 (5.0) 0.031 (W)
Glycemic control, n (%)
HbA1c < 7.0% (53 mmol/mol) 248/1109 (22) 165/653 (25) 77/416 (19) 0.010
Insulin regimen, n (%) <0.001 (C)
Basal alone 133/1275 (10) 42/717 (6) 88/514 (17) <0.001
Basal+prandial 651/1275 (51) 432/717 (60) 198/514 (39) <0.001
Others 80/1275 (6) 40/717 (6) 37/514 (7) 0.247
Prandial alone 30/1275 (2) 24/717 (3) 5/514 (1) 0.007
Premix alone 381/1275 (30) 179/717 (25) 186/514 (36) <0.001
Health insurance, n (%) 896/1299 (69) 542/737 (74) 317/514 (62) <0.001
Mean number of daily
injections according to
insulin used (SD)
Basal alone 1.6 (0.6) 1.5 (0.5) 1.7 (0.7) 0.214 (W)
Basal+prandial 3.9 (0.7) 4.0 (0.7) 3.8 (0.7) 0.007 (W)
Prandial alone 2.6 (0.6) 2.4 (0.5) 3.0 (0.8) 0.174 (W)
Premix alone 2.1 (0.4) 2.0 (0.3) 2.1 (0.4) 0.021 (W)
Diabetes management strategy used, n (%) <0.001 (C)
SMBGc 925/1232 (75) 607/738 (82) 318/494 (64) <0.001
Self-management (SMBG and ISA) 637/1180 (54) 434/711 (61) 203/469 (43) <0.001
No self-management 192/1180 (16) 75/711 (11) 117/469 (25) <0.001
C, Chi-squared test; ISA, insulin self-adjustment; SD, standard deviation; SMBG, self-monitoring of blood glucose; W, Wilcoxon test.
a Participants with missing data were not considered when reporting proportions of participants in categories listed.
b Data on diabetes education status were not available for 49 participants.
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Fig. 1 – Self-management* according to diabetes education
status†. *Data for participants who reported practicing ISA
alone (6% of overall population) are not presented; †Data for
Wave 3 are not presented, as this wave included centers in
Iran, whereas the participating countries were the same
between Waves 2 and 4. ISA, insulin self-adjustment;
SMBG, self-monitoring of blood glucose.
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 4 7 ( 2 0 1 9 ) 2 9 –3 6 33had HbA1c  8.0% (64 mmol/mol), compared with 42% of
those who did receive education (p = 0.003).
A similar association was observed between HbA1c levels
and self-management: 26% of participants who practiced
self-management attained target values and 41% had
HbA1c  8.0% (64 mmol/mol). In comparison, only 19% of
participants who did not practice self-management attained
target values (p = 0.007) while 51% had HbA1c  8.0%
(64 mmol/mol) (p < 0.001).
ISAwas also important for attainment of appropriate con-
trol of glucose metabolism: people who practiced SMBG with-
out ISAwere no more likely to attain target values than those
who practiced neither SMBG nor ISA (21% vs 17%, p = 0.437).
The effectiveness of self-management was favorably
affected by diabetes education. Among people who practiced
self-management, therewasanumericalnon-significant trend
towards higher attainment of HbA1c target value in those who
had receiveddiabetes education: 27%of participantswhoprac-
ticed self-management and had received diabetes education
attained HbA1c < 7.0% (<53 mmol/mol), compared with 23% ofFig. 2 – HbA1c percentage distribution according to diabetes
education status.participants who practiced self-management, but had not
received diabetes education (p = 0.280).
3.4. Multivariate analysis
Participants who received diabetes education were 2.5 times
more likely to practice self-management compared with
those who had not received it (OR: 2.51; 95% CI: 1.7–3.69;
p < 0.001). Other factors associated with the use of self-
management practices included age, time since diagnosis of
diabetes, general education level and insulin device (Fig. 3).
Of the factors tested for association with glycemic control
(self-management, diabetes education, diabetes complica-
tions, insulin regimen, age, BMI, gender, total daily insulin
dose, time since diagnosis, glucometer availability), self-
management was the only factor that showed a significant
association. Participants who practiced self-management
were 1.5 times more likely to attain HbA1c target values than
those who did not (OR: 1.49; 95% CI: 1.06–2.09; p = 0.023).4. Discussion
These data show significant positive associations between
diabetes education, self-management practices (SMBG and
ISA) and improved glucose metabolic control: people that
had received diabetes education were 2.5 times more likely
to perform self-management and those who practiced self-
management were 1.5 times more likely to have HbA1c < 7.0%
(<53 mmol/mol).
The beneficial effect of diabetes education on
self-management was not unexpected: SMBG and ISA are
complex procedures that can be difficult to perform appropri-
ately for an uneducated patient since having the disease does
not automatically give the patient sufficient knowledge on
how to control it. Further, these beneficial diabetes
self-management and education outcomes are consistent
with data reported previously [13–15].
Although the Diabetes Control and Complications Trial
(DCCT) outcomes provided strong evidence that strict glyce-
mic control reduces microvascular complications in people
with T1DM, the three-fold increase in severe hypoglycemia
associated with intensive insulin therapy presented a serious
challenge for its implementation in routine care [16]. How-
ever, there is increasing evidence that intensive insulin ther-
apy is not necessarily associated with a high risk of severe
hypoglycemia [5,17–20]. In fact, implementation of a 5-day
structured inpatient training course for intensive insulin ther-
apy (DTTP, developed by a German group), showed sustained
improvements in glycemic control after 22 months without
increasing the risk of severe hypoglycemia [17]. Similarly, in
the DAFNE trial, HbA1c and quality of life were significantly
improved after appropriate training, while the incidence of
severe hypoglycemia remained unchanged [19]. Although
the long-term sustainability of the improvement in glycemic
control observed in the DAFNE trial has been challenged,
an analysis using the Sheffield Type 1 diabetes mellitus
Policy Model showed that DAFNE was cost-effective for
the reduction of long-term complications and
increasing survival [21,22].
Age (40‒65 vs >65)
0 1 2 3 4 5 6 7 8 9 10 11 12
Less likely to practice
self-management
More likely to practice
self-management
OR [95% CI]
Age (<40 vs 40–65) OR: 2.09; 95% CI: 1.28, 3.41; p=0.003
OR: 3.53; 95% CI: 1.05, 11.85; p=0.041
Time since first diagnosis




OR: 2.25; 95% CI: 1.54, 3.31; p<0.001
Diabetes education
(yes vs no) OR: 2.51; 95% CI: 1.7, 3.69; p<0.001
Insulin administration
(Pen vs vial/syringes) OR: 1.86; 95% CI: 1.26, 2.75; p=0.002
Fig. 3 – Predictive factors for self-management. CI, confidence interval; OR, odds ratio.
34 d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 4 7 ( 2 0 1 9 ) 2 9 –3 6In our study, diabetes education, age, diabetes duration,
level of general education and type of insulin administration
were significant predictors for the practice of self-
management. Given the significant positive association
observed between self-management and degree of glycemic
control, these results suggest that provision of education
about self-management to people with T1DM early after diag-
nosis may help to maximize its beneficial effect on gly-
cometabolic control. Although access to diabetes education,
insulin, devices and strips for SMBG could also influence
our results, this does not appear to be the case because the
majority of participants in diabetes-educated and diabetes-
uneducated groups had healthcare coverage.
Unexpectedly, in this Middle East population, approxi-
mately 40% of participants had not received diabetes educa-
tion, regardless of whether they had been recruited by a
general practitioner or a diabetes specialist. However, we do
not know whether the type and extent of the education pro-
grams were alike in both groups. Nevertheless, this suggests
a need for an intensive promotion of diabetes education for
people with T1DM in the Middle East, even among people
already receiving specialist care. It is also important to pro-
mote the use of diabetes education programs in primary care
settings, as this has been shown to improve the quality of
care [23,24].
These data clearly show the beneficial impact of diabetes
self-management on attainment of glycemic target, and the
positive association between diabetes education and self-
management. However, these results should be considered
with caution because the data were the product of an obser-
vational study, and participating patients were under the care
of a selected group of physicians with experience in insulin
titration and administration. Therefore, these results may
not be representative of all physicians, nor the general popu-
lation of people with T1DM in this region. Consequently, the
true percentage of people with T1DM that have access to dia-
betes education may differ from that reported here across the
Middle East region. Nevertheless, due to the large size of this
sample and the standardizedmethod used for data collection,
our results provide objective evidence for health authorities
and decision makers about the benefits of diabetes education
and self-management to improve treatment outcomes. Thisassertion is supported by other studies that have shown a
similar positive association between self-management and
better treatment outcomes [9,25–27].
In summary, our findings show that diabetes education is
significantly associated with effective self-management in
people with T1DM, which in turn would favor the attainment
of HbA1c target. Diabetes education provides the knowledge
and skills to optimize self-management, but more impor-
tantly, induces a positive attitude towards patients’ active
participation in the control and treatment of their disease.
Thus, Middle East health authorities should invest great
efforts to facilitate access to education for people with
T1DM, in order to optimize treatment outcomes and prevent
the development of chronic complications.
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